Literature DB >> 20552285

Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma.

Masahiro Kikuchi1, Shogo Shinohara, Yuji Nakamoto, Yu Usami, Keizo Fujiwara, Tsunemichi Adachi, Shin-ya Hori, Yosuke Tona, Hiroshi Yamazaki, Yukihiro Imai, Yasushi Naito.   

Abstract

PURPOSE: To evaluate whether 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) more accurately predicts the histopathologic response to neoadjuvant chemotherapy (NAC) than magnetic resonance imaging (MRI) in patients with head and neck squamous cell carcinoma (HNSCC). PROCEDURES: Sixteen patients with HNSCC underwent FDG-PET/CT and MRI scans before and after one cycle of NAC, followed by surgical resection. The 26 surgically resected specimens of the 16 patients were analyzed. Decreases in maximum standardized uptake value (SUV(max)) or in tumor maximum size (diameter(max)) were calculated, and their accuracies for the prediction of histopathologic response were evaluated.
RESULTS: In histopathologic responders (n = 7), percent decreases in SUV(max) were significantly higher (P < 0.001) than in non-responders (n = 19). Applying a cut-off point of 55.5%, the histopathologic response could be predicted with a sensitivity and specificity of 86% and 95%, respectively.
CONCLUSION: FDG-PET/CT can predict histopathologic NAC responses with higher accuracy than MRI in HNSCC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20552285     DOI: 10.1007/s11307-010-0364-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  29 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

Authors:  W A Weber; K Ott; K Becker; H J Dittler; H Helmberger; N E Avril; G Meisetschläger; R Busch; J R Siewert; M Schwaiger; U Fink
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

4.  [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.

Authors:  Douglas S Hawkins; Scott M Schuetze; James E Butrynski; Joseph G Rajendran; Cheryl B Vernon; Ernest U Conrad; Janet F Eary
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

5.  FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.

Authors:  Eva Brun; Elisabeth Kjellén; Jan Tennvall; Tomas Ohlsson; Anders Sandell; Roland Perfekt; Roland Perfekt; Johan Wennerberg; Sven Erik Strand
Journal:  Head Neck       Date:  2002-02       Impact factor: 3.147

6.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

7.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

Authors:  Karen Becker; James D Mueller; Christoph Schulmacher; Katja Ott; Ulrich Fink; Raymonde Busch; Knut Böttcher; J Rüdiger Siewert; Heinz Höfler
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

8.  In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.

Authors:  Myriam Wartski; Elise Le Stanc; Eric Gontier; Didier Vilain; Alain Banal; Catherine Tainturier; Alain Paul Pecking; Jean Louis Alberini
Journal:  Nucl Med Commun       Date:  2007-05       Impact factor: 1.690

9.  Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer.

Authors:  K Al-Kourainy; J Kish; J Ensley; E Tapazoglou; J Jacobs; A Weaver; J Crissman; G Cummings; M Al-Sarraf
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

10.  Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.

Authors:  J F Ensley; J R Jacobs; A Weaver; J Kinzie; J Crissman; J A Kish; G Cummings; M Al-Sarraf
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860

View more
  9 in total

1.  Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma.

Authors:  Masahiro Kikuchi; Yuji Nakamoto; Shogo Shinohara; Keizo Fujiwara; Hiroshi Yamazaki; Yuji Kanazawa; Risa Kurihara; Ippei Kishimoto; Hiroyuki Harada; Yasushi Naito
Journal:  Int J Clin Oncol       Date:  2012-03-09       Impact factor: 3.402

Review 2.  Imaging strategies in the management of oesophageal cancer: what's the role of MRI?

Authors:  Peter S N van Rossum; Richard van Hillegersberg; Frederiek M Lever; Irene M Lips; Astrid L H M W van Lier; Gert J Meijer; Maarten S van Leeuwen; Marco van Vulpen; Jelle P Ruurda
Journal:  Eur Radiol       Date:  2013-02-13       Impact factor: 5.315

Review 3.  Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.

Authors:  Farzan Siddiqui; Min Yao
Journal:  World J Radiol       Date:  2014-06-28

4.  The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.

Authors:  Ka-Rham Kim; Hyun-Jeong Shim; Jun-Eul Hwang; Sang-Hee Cho; Ik-Joo Chung; Ki Seong Park; Sae-Ryung Kang; Seong Young Kwon; Woong-Ki Chung; Woo Kyun Bae
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-22       Impact factor: 9.236

Review 5.  Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

Authors:  Remco de Bree; Gregory T Wolf; Bart de Keizer; Iain J Nixon; Dana M Hartl; Arlene A Forastiere; Missak Haigentz; Alessandra Rinaldo; Juan P Rodrigo; Nabil F Saba; Carlos Suárez; Jan B Vermorken; Alfio Ferlito
Journal:  Head Neck       Date:  2017-08-17       Impact factor: 3.147

6.  Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.

Authors:  Ulisses Ribaldo Nicolau; Victor Hugo Fonseca de Jesus; Eduardo Nóbrega Pereira Lima; Marclesson Santos Alves; Thiago Bueno de Oliveira; Louise De Brot Andrade; Virgilio Souza Silva; Paula Cacciatore Bes; Tadeu Ferreira de Paiva; Vinicius Fernando Calsavara; Andrea Paiva Gadelha Guimarães; Loureno Cezana; Paula Nicole Vieira Pinto Barbosa; Gislaine Cristina Lopes Machado Porto; Antônio Cássio Assis Pellizzon; Genival Barbosa de Carvalho; Luiz Paulo Kowalski
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

7.  Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.

Authors:  Eduardo Bruno Lobato Martins; Rubens Chojniak; Luis Paulo Kowalski; Ulisses Ribaldo Nicolau; Eduardo Nóbrega Pereira Lima; Almir Galvão Vieira Bitencourt
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

Review 8.  Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review.

Authors:  Renata Fockink Dos Anjos; Dalton Alexandre Dos Anjos; Danielle Leal Vieira; André Ferreira Leite; Paulo Tadeu de Souza Figueiredo; Nilce Santos de Melo
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting pathological response to preoperative super-selective intra-arterial chemoradiotherapy for advanced squamous cell carcinoma of the mandible.

Authors:  Maiko Shibasaki; Toshinori Iwai; Senri Oguri; Toshiyuki Koizumi; Makoto Hirota; Kenji Mitsudo; Yukihiko Ozawa; Iwai Tohnai
Journal:  J Bone Oncol       Date:  2018-02-07       Impact factor: 4.072

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.